The progression of Alzheimer’s disease was arrested in four patients who received an intravenous antibody treatment over three years, researchers reported at a conference in Vancouver, British Columbia.

Researchers noted that the results were inconclusive since they involved such a small group of patients. But with Alzheimer’s still mostly a mystery to medical science, any small step forward in treatment is good news.

— Posted by Alexander Reed Kelly

MedPage Today:

… The highlight finding, Relkin said, was that 3-year ADAS-Cog and CGIC scores in the four patients who received 0.4 g/kg every 2 weeks throughout the study were the same as at baseline.

Untreated Alzheimer’s disease patients in his clinic nearly always show measurable decline in 3 to 6 months, he said.

Read more

 Your support is crucial...

As we navigate an uncertain 2025, with a new administration questioning press freedoms, the risks are clear: our ability to report freely is under threat.

Your tax-deductible donation enables us to dig deeper, delivering fearless investigative reporting and analysis that exposes the reality beneath the headlines — without compromise.

Now is the time to take action. Stand with our courageous journalists. Donate today to protect a free press, uphold democracy and uncover the stories that need to be told.

SUPPORT TRUTHDIG